← back to search

Marcello Tonelli

Institute of Public Health Zadar · CA
Area of research
Nephrology · Transplantation
Research interest
Research interests include Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Acute Kidney Injury Research, and Renal Transplantation Outcomes and Treatments.
h-index
162
citations
256,114
works
987
NIH funding
primary concept
Medicine
email

Recent publications

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
2026cited by 5position: contributordoi
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Kidney International 2026cited by 3position: contributordoi
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD).
2026cited by 1position: contributordoi
Diagnostic Yield of Various Serum Creatinine Testing Frequencies in People at Risk for CKD.
2026cited by 1position: contributordoi
Targeting the Pathogenesis of IgA Nephropathy - A New Treatment Approach?
2026cited by 0position: contributordoi
Bridging global kidney care gap through data: introducing the International Society of Nephrology-Global Kidney Health Atlas (ISN-GKHA) Interactive Map.
2026cited by 0position: contributordoi
A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis.
2026cited by 0position: contributordoi
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
2025cited by 470position: contributordoi
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
2025cited by 210position: contributordoi
Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
2025cited by 82position: contributordoi
Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
2025cited by 54position: contributordoi
Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
2025cited by 31position: contributordoi
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
2025cited by 19position: contributordoi
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial.
2025cited by 17position: contributordoi
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.
2025cited by 16position: contributordoi
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019.
2025cited by 14position: contributordoi
Frailty Assessment Tools in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
2025cited by 12position: contributordoi
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis
British Journal of Cancer 2025cited by 8position: contributordoi
Patient, Caregiver, and Provider Perspectives on Improving Provider-Patient Interactions in Hemodialysis: A Qualitative Study
Canadian Journal of Kidney Health and Disease 2025cited by 6position: middledoi
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.
2025cited by 5position: contributordoi
World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring.
2025cited by 5position: contributordoi
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
2025cited by 4position: contributordoi
Patient, Caregiver, and Provider Perspectives on Improving Provider-Patient Interactions in Hemodialysis: A Qualitative Study.
2025cited by 3position: contributordoi
Adsorption Dynamics of Uremic Toxins to Cyclodextrin-Coated Magnetic Nano-Adsorbents.
2025cited by 2position: contributordoi
Performance of Hearing Test Software Applications to Detect Hearing Loss.
2025cited by 2position: contributordoi
Global availability of medications and health technologies for kidney care: A multinational study from the ISN-GKHA.
2025cited by 2position: contributordoi
Associations of body fat and inflammation with non-communicable chronic diseases and mortality: a prospective cohort study of the UK Biobank.
2025cited by 1position: contributordoi
Closing CKD Treatment Gaps: Why Practice Guidelines and Better Drug Coverage Are Not Enough.
2025cited by 1position: contributordoi
Backbone and sidechain <sup>1</sup>H, <sup>15</sup>N and <sup>13</sup>C resonance assignments of a multidrug efflux membrane protein using solution and solid-state NMR.
2025cited by 1position: contributordoi
Guatemala's resolution on kidney health: a historic opportunity.
2025cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Aminu K. Bello · University of Alberta70 papers (2012–2025) · 68 papers (2019–2026)Jonathan C. Craig · Murdoch Children's Research Institute40 papers (2012–2023)Fergus Caskey · Health Data Research UK37 papers (2019–2025)David W Johnson · International Society of Nephrology34 papers (2019–2026)Scott Klarenbach · Alberta Health Services29 papers (2019–2023)Neesh Pannu · Alberta Kidney Disease Network21 papers (2012–2025)Ikechi G Okpechi · eHealth Initiative21 papers (2020–2025)Brenda R. Hemmelgarn · University of Alberta19 papers (2012–2019)Jo-Ann Donner · RELX Group (United States)19 papers (2020–2026)David W. Johnson · Mitsubishi Chemical (Germany)17 papers (2013–2024)Matthew T. James · University of Calgary16 papers (2012–2025)Giovanni FM Strippoli · The University of Sydney16 papers (2012–2021)Sara N Davison · Royal Darwin Hospital16 papers (2019–2025)Braden Manns · University of Calgary16 papers (2012–2019)Suetonia C. Palmer · University of Otago16 papers (2012–2021)Natasha Wiebe · Université de Montréal15 papers (2019–2026)Natasha Wiebe · University of Alberta14 papers (2012–2022)Paul Muntner · Diagnostics for the Real World (United States)13 papers (2012–2022)Valerie Luyckx · Universidade da Região de Joinville13 papers (2019–2024)